Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew P Levy

Showing results (11-20 of 134) with videos related to

Pageof 14
Sort By:
Expert Review of Cardiovascular Therapy|March 7, 2012
HDL dysfunction in diabetes: causes and possible treatmentsDan Farbstein, Andrew P Levy
Molecular and Cellular Biochemistry|June 20, 2008
Regulation of CD163 associated casein kinase II activity is haptoglobin genotype dependentMerav Strauss, Andrew P Levy
Cardiology Clinics|July 13, 2010
The genetics of vascular complications in diabetes mellitusDan Farbstein, Andrew P Levy
Journal of Cardiovascular Translational Research|March 27, 2012
Haptoglobin genotype and its role in diabetic cardiovascular diseaseTina Costacou, Andrew P Levy
Expert Review of Cardiovascular Therapy|November 27, 2007
Pharmacogenomics in prevention of diabetic cardiovascular disease: utilization of the haptoglobin genotype in determining benefit from vitamin EAndrew P Levy, Shany Blum
International Journal of Molecular Sciences|January 5, 2021
The Role of Haptoglobin Polymorphism in Cardiovascular Disease in the Setting of DiabetesShmuel Somer, Andrew P Levy
Clinical Chemistry|October 27, 2004
ELISA for determination of the haptoglobin phenotypeNina S Levy, Andrew P Levy
Atherosclerosis|March 1, 2011
Haptoglobin genotype and the iron hypothesis of atherosclerosisHilla Lee Viener, Andrew P Levy
Rambam Maimonides Medical Journal|August 3, 2013
Changing the face of diabetic care with haptoglobin genotype selection and vitamin eNina S Levy, Andrew P Levy
Experimental and Clinical Cardiology|August 4, 2009
Haptoglobin: A major susceptibility gene for diabetic vascular complicationsTal Szafranek, Stuart Marsh, Andrew P Levy
Pageof 14

Showing results (11-20 of 134) with videos related to

Sort By:
Pageof 14
Expert Review of Cardiovascular Therapy|March 7, 2012
HDL dysfunction in diabetes: causes and possible treatmentsDan Farbstein, Andrew P Levy
Molecular and Cellular Biochemistry|June 20, 2008
Regulation of CD163 associated casein kinase II activity is haptoglobin genotype dependentMerav Strauss, Andrew P Levy
Cardiology Clinics|July 13, 2010
The genetics of vascular complications in diabetes mellitusDan Farbstein, Andrew P Levy
Journal of Cardiovascular Translational Research|March 27, 2012
Haptoglobin genotype and its role in diabetic cardiovascular diseaseTina Costacou, Andrew P Levy
Expert Review of Cardiovascular Therapy|November 27, 2007
Pharmacogenomics in prevention of diabetic cardiovascular disease: utilization of the haptoglobin genotype in determining benefit from vitamin EAndrew P Levy, Shany Blum
International Journal of Molecular Sciences|January 5, 2021
The Role of Haptoglobin Polymorphism in Cardiovascular Disease in the Setting of DiabetesShmuel Somer, Andrew P Levy
Clinical Chemistry|October 27, 2004
ELISA for determination of the haptoglobin phenotypeNina S Levy, Andrew P Levy
Atherosclerosis|March 1, 2011
Haptoglobin genotype and the iron hypothesis of atherosclerosisHilla Lee Viener, Andrew P Levy
Rambam Maimonides Medical Journal|August 3, 2013
Changing the face of diabetic care with haptoglobin genotype selection and vitamin eNina S Levy, Andrew P Levy
Experimental and Clinical Cardiology|August 4, 2009
Haptoglobin: A major susceptibility gene for diabetic vascular complicationsTal Szafranek, Stuart Marsh, Andrew P Levy
Pageof 14